|
86 Companies |
|
134 Products |
|
134 Products |
|
85 Mechanisms of Action |
|
5 Trials |
|
1881 News |
|
| «12...56789101112131415...3738» |
- || Arvisol (cannabidiol) / Echo Pharma
Preclinical, Trial primary completion date: CBD-IS: Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study (clinicaltrials.gov) - Aug 21, 2015
P1, N=74, Recruiting, Sponsor: Central Institute of Mental Health, Mannheim
Trial primary completion date: Jun 2015 --> Oct 2015
- Enrollment closed, Trial primary completion date, Adherence: Effectiveness of Adherence Therapy for Schizophrenia (clinicaltrials.gov) - Aug 20, 2015
P1/2, N=134, Active, not recruiting, Sponsor: The Hong Kong Polytechnic University
Trial primary completion date: Jun 2015 --> Oct 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Dec 2015
- Trial completion, HEOR: Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders (clinicaltrials.gov) - Aug 20, 2015
P=N/A, N=251, Completed, Sponsor: Department of Veterans Affairs
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Dec 2015 Active, not recruiting --> Completed
- ||| Trial completion, Trial initiation date, Trial primary completion date: An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia (clinicaltrials.gov) - Aug 19, 2015
P=N/A, N=1433, Completed, Sponsor: Hoffmann-La Roche
Active, not recruiting --> Completed Recruiting --> Completed | Initiation date: Sep 2012 --> Feb 2011 | Trial primary completion date: Dec 2015 --> Dec 2014
- Enrollment closed: RECOVERY: RCT of Methotrexate Added to Treatment As Usual in Schizophrenia (clinicaltrials.gov) - Aug 18, 2015
P1, N=100, Active, not recruiting, Sponsor: Pakistan Institute of Learning and Living
Recruiting --> Completed | Initiation date: Sep 2012 --> Feb 2011 | Trial primary completion date: Dec 2015 --> Dec 2014 Recruiting --> Active, not recruiting
- Trial completion, Trial primary completion date: Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in Schizophrenia (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=26, Completed, Sponsor: University of Arkansas
Recruiting --> Active, not recruiting Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Aug 2015
- Trial primary completion date: Non-invasive Brain Stimulation for Auditory Verbal Hallucinations in Schizophrenia (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=30, Recruiting, Sponsor: Charite University, Berlin, Germany
Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Aug 2015 Trial primary completion date: Dec 2014 --> Dec 2015
- Trial primary completion date: Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia (clinicaltrials.gov) - Aug 14, 2015
P1/2, N=72, Recruiting, Sponsor: National Institute of Mental Health (NIMH)
Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Jul 2015 --> Jul 2017
- Trial primary completion date: Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=250, Recruiting, Sponsor: Centre Hospitalier Esquirol
Trial primary completion date: Jul 2015 --> Jul 2017 Trial primary completion date: Jul 2014 --> Jul 2016
- Trial primary completion date: The Topical Niacin Skin Flush Test in First Episode Psychosis (clinicaltrials.gov) - Aug 14, 2015
P3, N=100, Recruiting, Sponsor: Nova Scotia Health Authority
Trial primary completion date: Jul 2014 --> Jul 2016 Trial primary completion date: Jun 2015 --> Jun 2016
- mirtazapine / Generic mfg.
Trial primary completion date: RECOVERY2: Evaluation of Mirtazapine and Folic Acid for Schizophrenia: (clinicaltrials.gov) - Aug 14, 2015
P4, N=330, Recruiting, Sponsor: Capital Medical University
Trial primary completion date: Jun 2015 --> Jun 2016 Trial primary completion date: Sep 2012 --> Sep 2016
- Trial initiation date: Phase II Motivational Interviewing: An Experiential Online Training Tool (clinicaltrials.gov) - Aug 14, 2015
P2, N=3780, Not yet recruiting, Sponsor: Center for Social Innovation, Massachusetts
Trial primary completion date: Sep 2012 --> Sep 2016 Initiation date: Sep 2014 --> Sep 2015
- Trial primary completion date: Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in Schizophrenia (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=30, Active, not recruiting, Sponsor: University of Arkansas
Initiation date: Sep 2014 --> Sep 2015 Trial primary completion date: Jun 2015 --> Dec 2015
- Trial primary completion date: Therapeutic Efficacy of Transcranial Magnetic Stimulation in Schizophrenia (clinicaltrials.gov) - Aug 13, 2015
P2, N=30, Recruiting, Sponsor: Beth Israel Deaconess Medical Center
Trial primary completion date: Jun 2015 --> Dec 2015 Trial primary completion date: Jan 2015 --> Aug 2015
- Trial withdrawal, Trial primary completion date: Deep Brain Stimulation (DBS) for the Management of Treatment Refractory Negative Symptoms in Schizophrenia (clinicaltrials.gov) - Aug 13, 2015
P1, N=0, Withdrawn, Sponsor: Centre for Addiction and Mental Health
Trial primary completion date: Jan 2015 --> Aug 2015 Recruiting --> Withdrawn | Trial primary completion date: Sep 2016 --> Sep 2015
- aripiprazole / Generic mfg., quetiapine / Generic mfg., ziprasidone / Generic mfg.
Trial initiation date: PAFIP2: Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis (clinicaltrials.gov) - Aug 13, 2015
P4, N=203, Completed, Sponsor: Fundaci
Recruiting --> Withdrawn | Trial primary completion date: Sep 2016 --> Sep 2015 Initiation date: Feb 2005 --> Oct 2005
- |||| paliperidone extended release / Generic mfg.
Trial completion, Enrollment change: Efficacy and Safety of Paliperidone ER in First Episode Psychosis (clinicaltrials.gov) - Aug 13, 2015
P4, N=75, Completed, Sponsor: Chonbuk National University Hospital
Initiation date: Feb 2005 --> Oct 2005 Recruiting --> Completed | N=60 --> 75
- | Trial completion: TMS-Hz: High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Schizophrenia : a Randomized Controlled Study (clinicaltrials.gov) - Aug 12, 2015
P2/3, N=72, Completed, Sponsor: University Hospital, Caen
Recruiting --> Completed | N=60 --> 75 Recruiting --> Completed
- ||| quetiapine extended-release / Generic mfg.
Trial completion: Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=1400, Completed, Sponsor: AstraZeneca
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients With Schizophrenia (clinicaltrials.gov) - Aug 12, 2015
P2, N=10, Completed, Sponsor: Chiba University
Active, not recruiting --> Completed Recruiting --> Completed
- niacin extended-release formulation / Generic mfg.
Trial completion, Enrollment change: Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis (clinicaltrials.gov) - Aug 11, 2015
P3, N=22, Completed, Sponsor: Nova Scotia Health Authority
Recruiting --> Completed Recruiting --> Completed | N=45 --> 22
- Trial completion, Enrollment change, Trial primary completion date: ACT-IP: Acceptance and Commitment Therapy for the Inpatient Treatment of Psychosis (clinicaltrials.gov) - Aug 11, 2015
P0, N=18, Completed, Sponsor: Department of Veterans Affairs
Recruiting --> Completed | N=45 --> 22 Recruiting --> Completed | N=92 --> 18 | Trial primary completion date: Jul 2015 --> Apr 2015
- ||| ulotaront (SEP-363856) / Otsuka, PsychoGenics
Trial completion, Trial primary completion date: Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics (clinicaltrials.gov) - Aug 11, 2015
P1, N=105, Completed, Sponsor: Sunovion
Recruiting --> Completed | N=92 --> 18 | Trial primary completion date: Jul 2015 --> Apr 2015 Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Jul 2015
- | Trial completion: Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness (clinicaltrials.gov) - Aug 9, 2015
P2, N=60, Completed, Sponsor: Medical University of South Carolina
Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Jul 2015 No longer recruiting --> Completed
- Enrollment open: Transcranial Direct Current Stimulation Influences on Cognitive Inhibition in Schizophrenia (clinicaltrials.gov) - Jul 22, 2015
P=N/A, N=30, Recruiting, Sponsor: Bar-Ilan University, Israel
No longer recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment closed, Trial primary completion date: Study of Vitamin D in the Severely Mentally Ill (clinicaltrials.gov) - Jul 21, 2015
P=N/A, N=40, Active, not recruiting, Sponsor: Bronx Psychiatric Center
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Jun 2014
- Trial completion: Computerized Cognitive-Behavioral Therapy for Auditory Hallucinations (clinicaltrials.gov) - Jul 21, 2015
P=N/A, N=45, Completed, Sponsor: Boston University
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Jun 2014 Active, not recruiting --> Completed
- | Daliresp (roflumilast) / AstraZeneca, Takeda, AbbVie
Trial completion: Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia (clinicaltrials.gov) - Jul 17, 2015
P1, N=20, Completed, Sponsor: Takeda
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial primary completion date: Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism (clinicaltrials.gov) - Jul 15, 2015
P2, N=46, Active, not recruiting, Sponsor: Elizabeth Ralevski
Active, not recruiting --> Completed Trial primary completion date: Oct 2014 --> Dec 2015
- || aripiprazole / Generic mfg.
Trial primary completion date: Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI (clinicaltrials.gov) - Jul 15, 2015
P=N/A, N=90, Recruiting, Sponsor: University of British Columbia
Trial primary completion date: Oct 2014 --> Dec 2015 Trial primary completion date: Apr 2015 --> Sep 2015
- Trial primary completion date: Social Cognitive Training for Psychosis: Treatment Development (clinicaltrials.gov) - Jul 15, 2015
P1, N=40, Active, not recruiting, Sponsor: Yale University
Trial primary completion date: Apr 2015 --> Sep 2015 Trial primary completion date: May 2015 --> Sep 2015
- Trial primary completion date: Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders (clinicaltrials.gov) - Jul 13, 2015
P2, N=2, Enrolling by invitation, Sponsor: Mclean Hospital
Trial primary completion date: May 2015 --> Sep 2015 Trial primary completion date: Aug 2015 --> Nov 2015
- | Chantix (varenicline) / Pfizer
Trial completion, Enrollment change: Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia (clinicaltrials.gov) - Jul 13, 2015
P4, N=28, Completed, Sponsor: Centre for Addiction and Mental Health
Trial primary completion date: Aug 2015 --> Nov 2015 Recruiting --> Completed | N=50 --> 28
- Trial primary completion date: DCS: Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine (clinicaltrials.gov) - Jul 13, 2015
P0, N=2, Enrolling by invitation, Sponsor: Mclean Hospital
Recruiting --> Completed | N=50 --> 28 Trial primary completion date: Jan 2016 --> Sep 2016
- Trial primary completion date: Feeling of Being in Control of One's Own Action (clinicaltrials.gov) - Jul 13, 2015
P=N/A, N=370, Recruiting, Sponsor: University Hospital, Strasbourg, France
Trial primary completion date: Jan 2016 --> Sep 2016 Trial primary completion date: Oct 2015 --> Dec 2018
- Enrollment open, Enrollment change, Trial initiation date, Trial primary completion date: Mental Health and Cognitive Dysfunction: A Multicenter Study at Pediatric Rehabilitation Clinics in North Norway (clinicaltrials.gov) - Jul 9, 2015
P=N/A, N=320, Recruiting, Sponsor: University Hospital of North Norway
Trial primary completion date: Oct 2015 --> Dec 2018 Not yet recruiting --> Recruiting | N=100 --> 320 | Initiation date: Jan 2013 --> Oct 2012 | Trial primary completion date: Dec 2013 --> Jun 2016
- Enrollment open, Trial initiation date: Exercise and Cognitive Training (clinicaltrials.gov) - Jul 8, 2015
P0, N=30, Recruiting, Sponsor: Boston University
Not yet recruiting --> Recruiting | N=100 --> 320 | Initiation date: Jan 2013 --> Oct 2012 | Trial primary completion date: Dec 2013 --> Jun 2016 Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> May 2015
- olanzapine / Generic mfg., amisulpride / Generic mfg.
Trial primary completion date, Monotherapy: COMBINE: Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy (clinicaltrials.gov) - Jul 2, 2015
P4, N=399, Recruiting, Sponsor: Heinrich-Heine University, Duesseldorf
Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> May 2015 Trial primary completion date: Jun 2015 --> Aug 2016
- Aristada once-monthly (aripiprazole lauroxil once-monthly formulation) / Alkermes, Aristada two-month (aripiprazole lauroxil XR) / Alkermes
Enrollment closed: An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia (clinicaltrials.gov) - Jul 2, 2015
P1, N=140, Active, not recruiting, Sponsor: Alkermes, Inc.
Trial primary completion date: Jun 2015 --> Aug 2016 Recruiting --> Active, not recruiting
- AVL-3288 / Anvyl
Trial primary completion date: Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects (clinicaltrials.gov) - Jul 1, 2015
P1, N=80, Recruiting, Sponsor: University of Colorado, Denver
Recruiting --> Active, not recruiting Trial primary completion date: May 2015 --> May 2016
- Disalcid (salsalate) / Bausch Health
Enrollment closed, Trial initiation date: Salsalate as an Adjunctive Treatment for Patients With Schizophrenia (clinicaltrials.gov) - Jul 1, 2015
P4, N=15, Active, not recruiting, Sponsor: University of Massachusetts, Worcester
Trial primary completion date: May 2015 --> May 2016 Recruiting --> Active, not recruiting | Initiation date: Dec 2011 --> Jun 2011
- Trial completion, Enrollment change, Trial primary completion date: Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients (clinicaltrials.gov) - Jul 1, 2015
P1, N=12, Completed, Sponsor: University of Colorado, Denver
Recruiting --> Active, not recruiting | Initiation date: Dec 2011 --> Jun 2011 Recruiting --> Completed | N=100 --> 12 | Trial primary completion date: Jun 2016 --> Oct 2005
- Trial primary completion date: Contingency Management for Smoking Cessation Among Veterans With Psychotic Disorders (clinicaltrials.gov) - Jun 26, 2015
P=N/A, N=23, Terminated, Sponsor: Department of Veterans Affairs
Recruiting --> Completed | N=100 --> 12 | Trial primary completion date: Jun 2016 --> Oct 2005 Trial primary completion date: Jun 2013 --> Dec 2012
- |||| Trial completion: A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia (clinicaltrials.gov) - Jun 25, 2015
P4, N=353, Completed, Sponsor: Xian-Janssen Pharmaceutical Ltd.
Trial primary completion date: Jun 2013 --> Dec 2012 Active, not recruiting --> Completed
- ||||| Caplyta (lumateperone) - Intra / Cellular Therapies
Enrollment closed, Trial primary completion date: A Trial to Assess the Antipsychotic Efficacy of ITI-007 (clinicaltrials.gov) - Jun 24, 2015
P3, N=450, Active, not recruiting, Sponsor: Intra-Cellular Therapies, Inc.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Jul 2015
- Trial completion: IBASC: Improving Basic and Social Cognition in Veterans With Schizophrenia (clinicaltrials.gov) - Jun 24, 2015
P=N/A, N=72, Completed, Sponsor: Department of Veterans Affairs
Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Jul 2015 Suspended --> Completed
- Bydureon (exenatide XR once-weekly) / AstraZeneca
Trial completion: TAO: Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue (clinicaltrials.gov) - Jun 24, 2015
P3, N=45, Completed, Sponsor: Bjorn H. Ebdrup
Suspended --> Completed Recruiting --> Completed
- Trial completion: Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients (clinicaltrials.gov) - Jun 23, 2015
P=N/A, N=21, Completed, Sponsor: HaEmek Medical Center, Israel
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Enrollment change, Trial primary completion date: NeSSy: Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia (clinicaltrials.gov) - Jun 22, 2015
P4, N=149, Completed, Sponsor: University of Bremen
Active, not recruiting --> Completed Recruiting --> Completed | N=630 --> 149 | Trial primary completion date: Apr 2012 --> Aug 2013
- ||| olanzapine / Generic mfg., amisulpride / Generic mfg., clozapine / Generic mfg.
Enrollment change: OPTIMISE: Optimization of Treatment and Management of Schizophrenia in Europe (clinicaltrials.gov) - Jun 22, 2015
P4, N=500, Recruiting, Sponsor: Rene Kahn
Recruiting --> Completed | N=630 --> 149 | Trial primary completion date: Apr 2012 --> Aug 2013 N=350 --> 500